ARMI to get $300 mn in public─private investment to develop scalable manufacturing processes for engineered tissues & organs

09:35 EDT 5 May 2018 | PharmaBiz

Organovo Holdings, Inc. has joined a new public─private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI).

More From BioPortfolio on "ARMI to get $300 mn in public─private investment to develop scalable manufacturing processes for engineered tissues & organs"